Improvement patterns in schizophrenic 'nonresponders' treated with clozapine. A systematic study over 1 year

Nordic Journal of Psychiatry

Volumn 50, Issue 6, 1996, Pages 457-467

  Lingjærde, Odd ^a,b   Bela, Marek ^c   Krüger, Marit Bjartveit ^d   Dahle, Lars Gunnar ^e   Fossheim, Inge ^c   Helle, Jon ^f   Husebø, Børre ^g   Nybø, Geir ^h   Gjerstad, Birgit Teigland ⁱ   Torp, Håvard ^c   Ulstein, Ingunn ^c  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b Gaustad Hospital   (Norway)

^c Dikemark Hospital   (Norway)

^d Innherred Hospital   (Norway)

^e Dale Psychiatric Hospital   (Norway)

^f TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^g Psychiatric Department   (Norway)

^h Dept 3 ^*  (Norway)

ⁱ Psychiatric Department   (Norway)

Author keywords

Chronic schizophrenia; Clozapine; Drug treatment

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; DROWSINESS; DRUG EFFICACY; FEMALE; FOLLOW UP; GUILT; HUMAN; MALE; PROGNOSIS; RATING SCALE; SALIVATION; SCHIZOPHRENIA; SYMPTOM;

EID: 10544227749     PISSN: 08039496     EISSN: None     Source Type: Journal    
DOI: 10.3109/08039489609082514     Document Type: Article

References (21)

1. Kane J, Honigfeld G, Singer J, Meltzer HY, Clozaril Collaborative Study Group. Clozapine for the treatment resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-96.
2. Conley RR, Schulz SC, Baker RW, Collins JF, Bell JA. Clozapine efficacy in schizophrenic nonresponders. Psychopharmacol Bull 1988;24:269-74.
3. Erlandsen C. Utprøving av et nytt neuroleptikum, Leponex (clozapin) hos schizofrene med lang sykehistorie. Nord Psykiatr Tidsskr 1981;35: 248-53.
4. Pickar D, Owen RR, Litman RE, Konicki E, Gutierrez R, Rapaport MH. Clinical and biological response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Arch Gen Psychiatry 1992;49:345-53.
5. Tandon R, Goldman R, DeQuardo JR, Goldman M, Perez M, Jibson M. Positive and negative symptoms covary during clozapine treatment in schizophrenia. J Psychiatr Res 1993;27:341-7.
6. Shopsin B, Klein H, Aaronson M, Collora M. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients. Arch Gen Psychiatry 1997;36:657-64.
7. Shopsin B, Klein H, Aronsen M. Clozapine: double-blind control trial in the treatment of acute schizophrenia. Psychopharmacol Bull 1978;14: 12-5.
8. Ekblom B, Haggstrom JE. Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties. Curr Ther Res 1974;16:945-57.
9. Ratey JJ, Leveroni C, Kilmer D, Gutheil C, Swartz B. The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. J Clin Psychiatry 1993;54:219-23.
10. Leadbetter RA, Spears N, Shutty MS. Influence of clozapine on polydipsia and hyponatremia. American Psychiatric Association, 146th Annual Meeting. 1993 new research, program and abstracts, 1993:130.
11. Goldberg TE, Greenberg D, Griffin SJ, Gold JM, Kleinman JE, Pickar D, et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993;162:43-8.
12. Safferman AZ, Lieberman JA, Pollack S, Szymanski S, Masiar S, Johns C. Predictors of response to clozapine in chronic schizophrenia. Biol Psychiatry 1993;33 Suppl 6A:131A.
13. Owen RR, Beake BJ, Marby D, Dessain EC, Cole JO. Response to clozapine in chronic psychotic patients. Psychopharmacoll Bull 1989;25:253-6.
14. Jewart RD, Le wine RRJ, Manning DE, Risby ED, Risch SC. Brain MRI abnormalities associated with reduced antipsychotic response to clozapine in schizophrenic patients. Biol Psychiatry 1991;29 Suppl 9A:43A.
15. Kay SR. Positive and negative syndromes in schizophrenia. Assessment and research. New York: Brunner/Mazel, 1991.
16. Honigfeld G, Gillis RD, Klett CJ. Nurses' Observation Scale for Inpatient Evaluation. Washington: ECDEU, 1967:265-73.
17. Lingjærde O, Ahlfors UG, Bech P, Dencker SJ, Eigen K. The UKU side effect rating scale. Acta Psychiatr Scand 1987;76 Suppl 334.
18. Meltzer HY. The effect of clozapine and other atypical antipsychotic drugs on negative symptoms. In: Mameros A, Andreasen NC, Tsuang MT, editors. Negative versus positive schizophrenia. Berlin: Springer Verlag, 1991:365-76.
19. Claghorn J, Honigfeld G, Abuzzahab FS, Wang R, Steinbook R, Tuason V, et al. The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 1987;7:377-84.
20. Carpenter WT, Heinrichs DW, Wagman AMI. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988;145:578-83.
21. Lindenmayer J-P, Grochowski S, Mabugat L. Clozapine effects on positive and negative symptoms: A six-month trial of treatment-refractory schizophrenics. J Clin Psychopharmacol 1994;14: 201-4.